BCRX
BioCryst Pharmaceuticals
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
BCRX Profile
Biocryst Pharmaceuticals, Inc.
A biotechn company that develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases
Biological Technology
Invalid Date
03/04/1994
NASDAQ Stock Exchange
580
12-31
Common stock
4505 Emperor Blvd., Suite 200, Durham, North Carolina 27703
--
BioCryst Pharmaceuticals, Inc., a Delaware corporation, was originally established in 1986. The company is a global biotechnology company dedicated to improving the lives of patients with hereditary angioedema and rare diseases. Leveraging its expertise in structure-guided drug design, the company aims to develop first-in-class or first-in-class oral small molecule and injectable protein therapies for rare diseases that are difficult to treat.